SCHEMBL21905409

SCHEMBL21905409

C[C](C)c1ncc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.42
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
TSHR P16473 2/20 0.39
CYP2C9 P11712 1/20 0.39
APEX1 P27695 1/20 0.39
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 6/20 0.36
HTT P42858 3/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HSP90AA1 P07900 1/20 0.36
OPRK1 P41145 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
GPR27 Q9NS67 1/20 0.35
ALDH1A1 P00352 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692886 0.83 LMNA (0.42) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL18784152 0.80 PLAU (0.46) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL28002539 0.77 L3MBTL1 (0.44) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL3580724 0.76 L3MBTL1 (0.43) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL287761 0.76 LMNA (0.47) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL27417430 0.75 PLAU (0.42) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL23413510 0.74 LMNA (0.46) PLAULMNASMN1; SMN2TSHRCYP2C9
Hydrochloric Acid SCHEMBL20139726 0.74 LMNA (0.46) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL2760820 0.74 PLAU (0.48) PLAULMNASMN1; SMN2TSHRCYP2C9
SCHEMBL30143410 0.74 PLAU (0.48) PLAULMNASMN1; SMN2TSHRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200138028-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200138028-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES PRF1, NOX1, ARG1 PLAU 4673/4885LMNA 4450/4885SMN1; SMN2 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.